FDA orders 23andMe to stop selling genetic testing kit
23andMe, the maker of a genetic testing kit, has performed their test on over 400,000 individuals since 2007. But last Friday, the Food and Drug Administration ordered the company to stop selling its product, to consumers saying the mail-order tests haven't been proven to be effective and could dangerously mislead people about their health.
The agency did not cite any actual examples, but said it was concerned about 23andMe's direct-to-consumer test "because of the potential health consequences that could result from false positive or false negative assessments," The FDA also said that 23andMe had not adequately responded to requests additional information regarding the validity of the tests which claim to detect the genetic risk for more than 240 conditions and traits.
Fox 9 medical expert Dr. Archelle Georgiou discusses the FDA's move.